Kenny, J;
Doerholt, K;
Gibb, DM;
Judd, A;
Collaborative HIV Paediatric Study (CHIPS) Steering Committee, .;
(2017)
Who Gets Severe Gynecomastia Among HIV-Infected Children In The UK And Ireland?
Pediatric Infectious Disease Journal
, 36
(3)
pp. 307-310.
10.1097/INF.0000000000001424.
Preview |
Text
Judd_CHIPS%20gynaecomastia%20PIDJ%20short%20report%20resubmission.pdf - Accepted Version Download (328kB) | Preview |
Abstract
There are few data on gynecomastia in HIV-infected children. Within the UK/Ireland's national cohort, 56/1,873 (3%) HIV-infected children had gynecomastia, of which 10 (0.5%) were severe. All 10 had received antiretroviral therapy for a median of 27.5 [21,42] months; 4/10 had received efavirenz, 7/10 and 6/10 stavudine and/or didanosine respectively. Five were non-reversible, despite changing ART, and required breast reduction surgery.
Type: | Article |
---|---|
Title: | Who Gets Severe Gynecomastia Among HIV-Infected Children In The UK And Ireland? |
Location: | United States |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1097/INF.0000000000001424 |
Publisher version: | http://dx.doi.org/10.1097/INF.0000000000001424 |
Language: | English |
Additional information: | Copyright © 2016 Wolters Kluwer Health, Inc. This is the accepted manuscript version of this article published in Pediatric Infectious Disease Journal; the final published version of record can be found at http://dx.doi.org/10.1097/INF.0000000000001424 |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > MRC Clinical Trials Unit at UCL |
URI: | https://discovery-pp.ucl.ac.uk/id/eprint/1530174 |
Archive Staff Only
View Item |